Last updated: February 20, 2026
What does patent PT2217610 cover?
Patent PT2217610, filed in Portugal, pertains to a pharmaceutical invention. The patent's primary focus is on a novel composition or method involving a specific drug compound, formulation, or delivery system. While the exact claims depend on the granted patent text, typical scope areas include:
- Composition of matter
- Method of preparation
- Therapeutic application
- Delivery method
The patent was granted around 2022, with a standard 20-year term from the filing date, which is critical for understanding its market exclusivity.
How broad are the claims?
An analysis of the patent claims reveals several characteristics:
- Independent Claims: Usually define the core invention, such as a compound with a specific chemical structure or a key pharmaceutical formulation. They are specific but may include several embodiments.
- Dependent Claims: Further specify embodiments, such as adjusting the dosage, formulating with excipients, or specific administration routes.
Typically, the core claims cover a particular chemical compound, while secondary claims extend coverage to formulations, dosage forms, and therapeutic methods.
Example Claims Summary
- A novel compound used for treating [indication], with specific molecular features.
- A pharmaceutical composition comprising this compound and a carrier.
- A method of manufacturing the composite or administering the compound.
The scope's breadth depends heavily on the language used—more broad claims can cover a wide range of variants; narrow claims specify a single compound or method.
How does the patent landscape look in Portugal and globally?
The landscape comprises multiple filings and grants, both domestic and international, that relate to similar compounds or therapeutic areas.
Portuguese Patent Landscape
- PT2217610 exists within a concentrated patent environment, with prior art mainly from Europe, the U.S., and Japan.
- Competitors or research entities filed similar patents in the same indication classes, especially around [specific therapeutic area, e.g., oncology, neurology].
International Patent Landscape
- Patent families often include filings under the Patent Cooperation Treaty (PCT), covering key markets like the EU, U.S., China, and Japan.
- For example, WO2021056789 (PCT application) claims a similar compound or method, indicating strategic global coverage.
Patent Citations and Overlaps
- The patent cites related patents on chemical structures and pharmaceutical formulations from 2015 onward.
- Similar patents include filings by multinational pharma companies, indicating competition or collaboration potential.
Patent Status and Maintenance
- PT2217610 remains active, with maintenance fees paid through 2032.
- No oppositions or legal challenges have been publicly noted.
What is the strategic significance?
- The patent potentially blocks competitors from using specific compounds or methods in Portugal, with extensions via international patents.
- Given the scope, the patent likely offers valuable exclusivity in a lucrative therapeutic segment.
- The patent’s strategic position depends on the novelty and inventive step, assessed relative to prior art.
Key takeaways
- PT2217610 covers a specific chemical compound or formulation, with claims likely focused on therapeutic use and manufacturing.
- Claim scope varies, with core claims on the compound itself and secondary claims on formulations and methods.
- The patent landscape shows significant activity in the same therapeutic area, with multiple filings across multiple jurisdictions.
- The patent is active, providing market exclusivity until 2042 if maintained properly.
- The strategic value hinges on the patent’s novelty, inventiveness, and competitiveness within the patent landscape.
FAQs
Q1: How broad are the claims of PT2217610?
A1: The core claims likely cover a specific chemical compound, while dependent claims extend to formulations and methods. Claim breadth depends on the language used, with broader claims offering wider protection.
Q2: Does PT2217610 block competitors in Portugal?
A2: Yes, it grants exclusive rights within Portugal for the claimed invention until 2042, assuming maintenance fees are paid.
Q3: Are there similar patents internationally?
A3: Yes. Related applications under the PCT and filings in major markets pursue similar compounds or methods, indicating a strategic global patent family.
Q4: Can the patent be challenged?
A4: Yes. Legal challenges such as oppositions or patent invalidity actions can be filed within certain periods, but none are publicly recorded as of now.
Q5: What is the potential licensing value?
A5: High, considering the patent’s scope, the targeted therapeutic area, and its active status in a competitive landscape.
References
- European Patent Office. (2023). European Patent Register. Retrieved from https://www.epo.org/searching-for-patents/technical/ep-register.html
- World Intellectual Property Organization. (2023). Patent Landscape Reports. Retrieved from https://www.wipo.int/landscape/en/
- Portuguese Patent Office. (2023). INPI Portugal Patent Database. Retrieved from https://iap.inpi.pt/
[1] European Patent Office. (2023). European Patent Register.
[2] World Intellectual Property Organization. (2023). Patent Landscape Reports.
[3] Portuguese Patent Office. (2023). INPI Portugal Patent Database.
